The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Isomonit Retard 60 mg Prolonged-release tablets

60 milligram(s) Prolonged-release tablet

Rowex LtdPA0711/023/001

Main Information

Trade NameIsomonit Retard 60 mg Prolonged-release tablets
Strength60 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderRowex Ltd
Licence NumberPA0711/023/001

Group Information

ATC CodeC01DA Organic nitrates
C01DA14 isosorbide mononitrate


Licence Issued10/12/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back